All lobbying filings

WELSH ROSE, LLC

WELSH ROSE, LLC filed a Q3 report for U.S. RENAL CARE on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for U.S. RENAL CARE · Provider of dialysis services.

All filings by WELSH ROSE, LLC · Everything U.S. RENAL CARE has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Texas

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Dialysis reimbursement issues and issues related to the Medicare Secondary Payer program. H.R. 6214, Kidney Care Access Protection Act.

Bills named in this filing 1

H.R. 6214
Kidney Care Access Protection Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.